Molson Coors Beverage Company
41.21USD
-0.4600 (-1.10%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on TAP.
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 12.8B | 13.9B | 13.7B | 13.0B | 11.1B | 11.1B |
| Q1 | 2.6B | 2.8B | 3.0B | 2.7B | — | — |
| Q2 | 3.5B | 3.9B | 3.8B | 3.7B | 3.6B | — |
| Q3 | 3.5B | 3.9B | 3.6B | 3.5B | 2.9B | — |
| Q4 | 3.1B* | 3.3B* | 3.2B* | 3.1B* | 2.7B | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | -.810 | 4.37 | 5.35 | -10.75 | 4.70 | 4.80 |
| Q1 | .696 | .334 | .970 | .590 | — | — |
| Q2 | .217 | 1.57 | 2.03 | 2.13 | 1.23 | — |
| Q3 | .994 | 1.98 | .960 | -14.79 | 1.46 | — |
| Q4 | -2.72* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
Revenue to net income
| .475* |
| 1.37* |
| 1.20* |
| 1.02 |
| — |
Debt level and coverage